Crescent Capital BDC (NASDAQ:CCAP) Rating Lowered to Market Perform at Keefe, Bruyette & Woods

Crescent Capital BDC (NASDAQ:CCAP) was downgraded by equities research analysts at Keefe, Bruyette & Woods from an “outperform” rating to a “market perform” rating in a research note issued on Friday, Marketbeat.com reports. They presently have a $17.00 price target on the stock, down from their prior price target of $18.50. Keefe, Bruyette & Woods’ price target indicates a potential upside of 10.25% from the stock’s current price.

Separately, Wells Fargo & Company dropped their target price on Crescent Capital BDC from $18.00 to $16.00 and set an “equal weight” rating on the stock in a research report on Monday, April 28th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $17.60.

Crescent Capital BDC Stock Down 3.3%

CCAP opened at $15.42 on Friday. The business has a 50 day moving average price of $16.19 and a two-hundred day moving average price of $18.07. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18. The company has a market cap of $571.47 million, a PE ratio of 7.75 and a beta of 0.63. Crescent Capital BDC has a 52 week low of $13.54 and a 52 week high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP) last posted its quarterly earnings data on Wednesday, May 14th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.52 by ($0.07). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The company had revenue of $42.13 million for the quarter, compared to analysts’ expectations of $45.08 million. As a group, research analysts anticipate that Crescent Capital BDC will post 2.09 EPS for the current year.

Institutional Investors Weigh In On Crescent Capital BDC

Institutional investors and hedge funds have recently modified their holdings of the company. Montag A & Associates Inc. acquired a new stake in shares of Crescent Capital BDC in the 4th quarter worth approximately $35,000. C M Bidwell & Associates Ltd. acquired a new stake in shares of Crescent Capital BDC in the 4th quarter worth approximately $39,000. Aquatic Capital Management LLC acquired a new stake in shares of Crescent Capital BDC in the 4th quarter worth approximately $129,000. Generation Capital Management LLC acquired a new stake in shares of Crescent Capital BDC in the 4th quarter worth approximately $192,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Crescent Capital BDC in the 4th quarter worth approximately $218,000. Institutional investors and hedge funds own 49.46% of the company’s stock.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.